Cochlear Falls on Stalling Developed Market Sales

Cochlear Ltd., maker of the world’s top-selling ear implant, fell by the most in 16 months in Sydney trading after announcing stalling growth in developed markets that contribute more than 80 percent of sales.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.